GSK
Stock Forecast, Prediction & Price Target
GSK Financial Estimates
GSK Revenue Estimates
GSK EBITDA Estimates
GSK Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $34.11B N/A | $29.32B -14.04% | $30.32B 3.42% | Avg: $33.63B Low: $32.90B High: $34.31B avg. 10.91% | Avg: $35.59B Low: $35.09B High: $36.09B avg. 5.80% | Avg: $46.99B Low: $46.33B High: $47.66B avg. 32.03% | Avg: $47.11B Low: $46.45B High: $47.78B avg. 0.26% |
Net Income
% change YoY
| $4.38B N/A | $4.92B 12.22% | $4.92B 0.14% | Avg: $6.49B Low: $5.96B High: $7.05B avg. 31.72% | Avg: $7.15B Low: $6.66B High: $7.78B avg. 10.22% | Avg: $17.44B Low: $17.12B High: $17.76B avg. 143.78% | Avg: $17.44B Low: $17.13B High: $17.77B avg. 0.03% |
EBITDA
% change YoY
| $8.78B N/A | $8.80B 0.21% | $9.13B 3.78% | Avg: $9.50B Low: $9.29B High: $9.69B avg. 4.02% | Avg: $10.05B Low: $9.91B High: $10.20B avg. 5.80% | Avg: $13.27B Low: $13.09B High: $13.46B avg. 32.03% | Avg: $13.31B Low: $13.12B High: $13.50B avg. 0.26% |
EPS
% change YoY
| $1.37 N/A | $1.22 -10.94% | $1.22 0% | Avg: $1.58 Low: $1.45 High: $1.72 avg. 29.60% | Avg: $1.75 Low: $1.62 High: $1.89 avg. 10.41% | Avg: $4.24 Low: $4.17 High: $4.32 avg. 143.04% | Avg: $4.24 Low: $4.17 High: $4.32 avg. 0.03% |
Operating Expenses
% change YoY
| $16.31B N/A | $13.33B -18.22% | $15.01B 12.60% | Avg: $10.61B Low: $10.38B High: $10.83B avg. -29.29% | Avg: $11.23B Low: $11.07B High: $11.39B avg. 5.80% | Avg: $14.83B Low: $14.62B High: $15.04B avg. 32.03% | Avg: $14.87B Low: $14.66B High: $15.08B avg. 0.26% |
FAQ
What is GSK stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 46.44% in 2025-2028.
We have gathered data from 7 analysts. Their low estimate is 5.96B, average is 6.49B and high is 7.05B.
What is GSK stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 12.25% in 2025-2028.
We have gathered data from 10 analysts. Their low revenue estimate is $32.90B, average is $33.63B and high is $34.31B.
What is GSK stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 45.77% in 2025-2028.
We have gathered data from 7 analysts. Their low earnings per share estimate is $1.45, average is $1.58 and high is $1.71.
What is the best performing analyst?
In the last twelve months analysts have been covering GSK stock. The most successful analyst is Peter Welford.